# A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer

> **NCT05919095** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 37 (estimated)

## Conditions studied

- Unresectable Gallbladder Cancer

## Interventions

- **DRUG:** Carrilizumab plus GEMOX

## Key facts

- **NCT ID:** NCT05919095
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919095, "A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05919095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*